//fpnotebook.com/
Ortho-Novum 7/7/7
Aka: Ortho-Novum 7/7/7, Ortho Novum 7/7/7, Ortho-Novum 777, Ortho Novum 777, Ortho-Novum 10/11, Necon 10/11, Necon 7/7/7, Nortrel 7/7/7, Tri-Norinyl, Leena, TriNovum, BiNovum, Synphase, Pirmella 7/7/7
- See Also
- Oral Contraceptive
- Oral Contraceptive Drug Interaction
- Oral Contraceptive Selection
- Oral Contraceptive Side Effect Management
- Oral Contraceptive-Related Uterine Bleeding Management
- Preparations (Norethindrone / Ethinyl Estradiol)
- Biphasics
- Ortho-Novum 10/11 or Necon 10/11 (0.5 - 1.0 / 35)
- BiNovum (UK, 0.5 - 1.0 / 35)
- Triphasics
- Ortho-Novum 7/7/7, Necon 7/7/7 or Nortrel 777 (0.5 - 0.75 - 1.0 / 35)
- TriNovum (UK, 0.5 - 0.75 - 1.0 / 35)
- Tri-Norinyl or Leena (0.5 - 1.0 - 0.5 / 35)
- Synphase (UK, 0.5 - 1.0 - 0.5 / 35)
- Components
- Norethindrone 0.5 to 1.0 (see preparations above)
- Ethinyl Estradiol 35 ug
- Effect
- Relative Progestational Activity: 0.8 (moderate)
- Estrogenic Activity: 48 (high)
- Androgenic Activity: 0.25 (moderate)
- Pill associated problems
- Indications to switch to Ortho Cyclen
- Acne Vulgaris (lower androgen)
- Increased Appetite (lower Progestin)
- Major Depression provoked (lower Progestin)
- Indications to switch to Demulen 1/35
- Breast Tenderness or engorgement (lower Estrogen)
- Break-through bleed days 10-21 (more Progestin)
- Headaches (lower Estrogen)
- Heavy Menses (more Progestin or less Estrogen)
- Dysmenorrhea or Menstrual Cramps (more Progestin)
- Moodiness (less Estrogen or more Progestin)
- Weight gain (less Estrogen or more Progestin)
- Indications to switch to Modicon
- Break-through bleed days 1-9 (more Estrogen)
- Break-through bleed all of month (more Estrogen)
- Menses too light (more Estrogen, less Progestin)
- Indications to switch to Nordette
- Libido decreased (more androgen)
- References
- Cerel-Suhl (1999) Am Fam Physician 60(7):2073 [PubMed]
- Speroff (1993) Obstet Gynecol 81:1034-47 [PubMed]
- Dickey (1998) Managing Contraceptive Pill Patients